Table 3. Multivariable exponential regression model for overall survival.
estimate | sd | z | HR | 95% CI Lower | 95% CI Upper | p value | |
---|---|---|---|---|---|---|---|
(Intercept) | 7.82 | 0.38 | 20.6 | ||||
Age (each 5 yrs) | -0.173 | 0.0264 | -6.57 | 1.19 | 1.13 | 1.25 | <0.001 |
Pleural Invasion (yes.vs.no) | -0.271 | 0.124 | -2.19 | 1.31 | 1.03 | 1.67 | 0.029 |
Tumor Size | |||||||
T1a (baseline group) | - | - | - | 1.0 | - | - | |
T1b | -0.298 | 0.137 | -2.17 | 1.35 | 1.03 | 1.76 | 0.030 |
T2a | -0.481 | 0.138 | -3.48 | 1.62 | 1.23 | 2.12 | <0.001 |
T2b | -0.768 | 0.177 | -4.34 | 2.16 | 1.52 | 3.05 | <0.001 |
T3 | -0.892 | 0.221 | -4.03 | 2.44 | 1.58 | 3.77 | <0.001 |
Performance status: some symptoms vs. normal | -0.272 | 0.103 | -2.64 | 1.31 | 1.07 | 1.61 | 0.008 |
Performance status: < 50% of time in bed vs. normal | -1.09 | 0.305 | -3.56 | 2.97 | 1.63 | 5.4 | <0.001 |
Gender F vs. M | 0.325 | 0.104 | 3.14 | 0.722 | 0.59 | 0.885 | <0.001 |
Histology: Squamous vs. Adenocarcinomas | -0.203 | 0.121 | -1.68 | 1.22 | 0.967 | 1.55 | 0.093 |
Histology: Other non-small cell vs. Adenocarcinomas | -0.0722 | 0.134 | -0.537 | 1.07 | 0.826 | 1.4 | 0.592 |